Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence
![Appraising ultra orphan drugs cover page](https://www.ohe.org/wp-content/uploads/2018/03/Appraising-ultra-orphan-drugs-cover-page_0.jpg)
Health care systems organise the finance and delivery of health care. They vary by country, reflecting specific history, culture, and economics. To maximise coverage and efficiency they must evolve with changing demographics, needs, and technologies.